Literature DB >> 1541310

Metabolic effects of carteolol and dilevalol in essential hypertension.

T Baba, K Takebe, T Tomiyama.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541310     DOI: 10.1007/bf00314932

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


× No keyword cloud information.
  9 in total

1.  Effect of propranolol on HDL cholesterol concentrations.

Authors:  D Streja; D Mymin
Journal:  Br Med J       Date:  1978-11-25

2.  Pharmacokinetics and absolute bioavailability of carteolol, a new beta-adrenergic receptor blocking agent.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Kushida; Y Horai; K Chiba; T Suganuma
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 3.  The effects of antihypertensive agents on serum lipids and lipoproteins.

Authors:  C K Lardinois; S L Neuman
Journal:  Arch Intern Med       Date:  1988-06

Review 4.  Preclinical pharmacologic properties of dilevalol, an antihypertensive agent possessing selective beta 2 agonist-mediated vasodilation and beta antagonism.

Authors:  E J Sybertz; R W Watkins
Journal:  Am J Cardiol       Date:  1989-06-05       Impact factor: 2.778

5.  Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients.

Authors:  J Rouffy; J Jaillard
Journal:  Am J Med       Date:  1984-02-27       Impact factor: 4.965

6.  Concentration-effect and time-effect relationships of carteolol.

Authors:  T Ishizaki; A Ohnishi; T Sasaki; K Chiba; T Suganuma; K Kushida
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Effects of pindolol and metoprolol on plasma lipids and lipoproteins.

Authors:  C Pasotti; A Capra; G Fiorella; C Vibelli; S M Chierichetti
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 8.  New insights and new approaches for the treatment of essential hypertension: selection of therapy based on coronary heart disease risk factor analysis, hemodynamic profiles, quality of life, and subsets of hypertension.

Authors:  M C Houston
Journal:  Am Heart J       Date:  1989-04       Impact factor: 4.749

9.  Effect of propranolol and prazosin on blood lipids. The Oslo Study.

Authors:  P Leren; P O Foss; A Helgeland; I Hjermann; I Holme; P G Lund-Larsen
Journal:  Lancet       Date:  1980-07-05       Impact factor: 79.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.